Table 3.
Patients’ characteristics (stratified by the diagnosis of TsH)
| Hernias (n = 124) | No hernias (n = 233) | p | |
|---|---|---|---|
| Gender | 101 F/23 M | 177 F/56 M | 0.23 |
| Age (years) | 43 ± 10 (range 21–64) | 43 ± 12 (range 21–75) | 0.83 |
| BMI (at surgery) | 49 ± 8 (range 33–78) | 50 ± 8 (range 31–80) | 0.72 |
| BMI (at follow-up) | 35 ± 7 (range 23–57) | 35 ± 7 (range 21–59) | 0.30 |
| Smoking | 34 (27.42%) | 76 (32.62%) | 0.63 |
| DM II | 51 (41.1%) | 78 (29.8%) | 0.16 |
| Sleeve | 44 (31.5%) | 70 (32.5%) | 0.39 |
| RYGB | 72 (60.3%) | 152 (63.2%) | |
| Other | 8 (8.2%) | 11 (4.19%) | |
| Fascia closure | 27 (21.77%) | 45 (19.31%) | 0.58 |
| ASA score | 0.65 | ||
| II | 9 (7.3%) | 14 (6%) | |
| III/IV | 115 (92.7%) | 219 (94%) | |
| LOS (min) | 121 ± 63 (range 44–501) | 121 ± 61 (range 48–556) | 0.99 |
| LOHS (days) | 6 ± 2 (range 3–23) | 6 ± 2 (range 4–24) | 0.61 |
| Follow-up (months) | 36 ± 28 (range 9–119) | 38 ± 28 (range 10–117) | 0.41 |
| Early complications | < 0.001 | ||
| CD 0/I/II | 120 (98.2%) | 226 (65.3%) | |
| CD III/IV | 4 (1.8%) | 14 (34.7%) | |
| WHD | 4 (3.22%) | 3 (1.28%) | 0.24 |
| EWL | 0.58 ± 0.25 (range − 0.60–1.13) | 0.63 ± 0.24 (range − 0.09–1.62) | 0.05 |
F female, M male, BMI body mass index (kg/m2), DM II type II diabetes mellitus, RYGB Roux-en-y gastric bypass, TsH trocar site hernia, ASA American Society of Anesthesiology, LOS length of surgery, LOHS length of hospital stay, CD Clavien-Dindo classification, WHD wound healing disorders